Developer docs
API playgroundTry for free, no card

Search company profiles

Agetech Capital

Full company profile

uuid00q2byb

Namestring
Agetech Capital
Websiteurl
agetechcapital.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

AgeTech Capital is a privately held venture capital firm founded in 2022 that invests in technology companies serving the aging population and the longevity economy. The firm is structured around a dedicated AgeTech thesis spanning aging-in-place solutions, healthcare technology, and financial services for older adults, and it is currently raising a $50 million first fund. Its disclosed portfolio to date consists of two Canadian investments: June Health, a women's healthcare platform with AI-enabled health navigation and multidisciplinary virtual care, in which AgeTech Capital participated in a CAD$2.4 million pre-seed round, and Common Wealth, a Toronto-based fintech providing workplace retirement plans to small and mid-sized employers, in which it participated in a CAD$12 million Series A.

AgeTech Capital does not sell a product or operate a technology platform; its revenue mechanics will, once the first fund closes, derive from conventional venture fund economics — typically a management fee on committed capital and a carried-interest share of fund returns. The firm's go-to-market is two-sided: it raises capital from limited partners into the fund vehicle and deploys that capital into early-stage AgeTech and longevity-adjacent companies, in some cases co-investing with sector-specialist or institutional partners. The website (agetechcapital.com) is live but currently displays a verification/loading state, and no headcount, office locations, founding-partner names, or LP roster are disclosed in the available sources.

The firm positions itself as a specialist in a structurally growing demographic segment — the over-65 population — targeting investment gaps where generalist capital is reportedly under-allocated. Operating geographies are not formally disclosed, but both known portfolio companies and several co-investors are Canada-based, suggesting an initial Canadian focus that may broaden as the fund matures.

Short descriptiontext

AgeTech Capital is a venture capital firm founded in 2022 that invests in early-stage technology companies serving the aging population and longevity economy, currently raising a $50M debut fund with portfolio investments in Canadian healthcare and fintech.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Keyword5 values
venture capital fund, agetech investments, longevity economy, aging population solutions, healthcare technology investing
Industry2 codes
1Financial Services / Fintech Growth Equity
CodeFSANACAEPrimaryYes
2Technology & Software Growth Equity
CodeFSANACAAPrimaryNo
NAICS code2 codes
  • Other Financial Investment Activities5239
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Private Equity Investing
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

AgeTech Capital is a venture capital fund that invests private capital into technology companies serving the aging population and the longevity economy. The firm provides equity financing and strategic support to early-stage and later-stage AgeTech startups developing aging-in-place solutions, healthcare technology, and financial services for older adults. The firm is currently raising a $50 million first fund dedicated to the AgeTech/longevity vertical.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AgeTech Capital is a venture capital fund, not a product company. Based on the available source data, AgeTech Capital is described as raising a $50M first fund focused on AgeTech and longevity investing, with portfolio companies including June Health and Common Wealth.

Product and service1 record
1AgeTech Capital Fund I
CategoryVenture Capital Fund
Description

A venture capital fund that invests in technology companies serving the aging population and the longevity economy. The fund deploys capital into early-stage and later-stage startups developing aging-in-place solutions, healthcare technology, and financial services for older adults. The product is targeted at limited partners (institutional investors, family offices, high-net-worth individuals) who commit capital to the fund.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
1Generator Ventures
TypeDirect peer
Description

Venture firm focused exclusively on AgeTech and the longevity economy, investing across aging-in-place, healthcare, and senior care tech. Directly comparable by vertical, stage, and check size.

2Longevity Vision Fund
TypeDirect peer
Description

Venture fund investing in technologies extending healthy human longevity, including healthspan, biotech, and AgeTech adjacencies. Comparable thematic focus with a broader biotech/healthspan overlay.

3Primetime Partners
TypeDirect peer
Description

US-based venture firm investing in companies serving adults aged 50+. Closest direct peer given comparable AgeTech/longevity thesis and stage focus on consumer, healthcare, and financial services for older adults.

4Ziegler Link-age Funds
TypeDirect peer
Description

Long-standing AgeTech-focused investment platform backed by Ziegler, targeting later-stage and growth equity opportunities in aging-services companies. Comparable vertical with a more growth-stage tilt.

5The K Fund
TypeEmerging player
Description

Early-stage AgeTech-focused venture fund. Comparable by vertical and stage, though typically writing smaller initial checks than AgeTech Capital's profile.

6Pivotal Ventures
TypeBroad incumbent
Description

Investment and incubation vehicle founded by Melinda French Gates, with explicit focus on aging/longevity among other priorities. Comparable thematic exposure but with much larger capital base and broader mandate.

7AgeTech West / AGE-WELL
TypeOthers
Description

Canadian aging-technology research and commercialization network. Comparable by geography and AgeTech focus, though structured as a research network rather than a pure VC fund — useful for sourcing and partnership comparisons.

8Reckon Point Ventures
TypeEmerging player
Description

Emerging manager deploying capital into aging-services and senior-care technology businesses. Comparable by vertical though at earlier stage and smaller fund size.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Agetech Capital

Venture Capital / Private Equity Investingagetechcapital.com

AgeTech Capital is a venture capital firm founded in 2022 that invests in early-stage technology companies serving the aging population and longevity economy, currently raising a $50M debut fund with portfolio investments in Canadian healthcare and fintech.

What Agetech Capital does

AgeTech Capital is a privately held venture capital firm founded in 2022 that invests in technology companies serving the aging population and the longevity economy. The firm is structured around a dedicated AgeTech thesis spanning aging-in-place solutions, healthcare technology, and financial services for older adults, and it is currently raising a $50 million first fund. Its disclosed portfolio to date consists of two Canadian investments: June Health, a women's healthcare platform with AI-enabled health navigation and multidisciplinary virtual care, in which AgeTech Capital participated in a CAD$2.4 million pre-seed round, and Common Wealth, a Toronto-based fintech providing workplace retirement plans to small and mid-sized employers, in which it participated in a CAD$12 million Series A.

AgeTech Capital does not sell a product or operate a technology platform; its revenue mechanics will, once the first fund closes, derive from conventional venture fund economics — typically a management fee on committed capital and a carried-interest share of fund returns. The firm's go-to-market is two-sided: it raises capital from limited partners into the fund vehicle and deploys that capital into early-stage AgeTech and longevity-adjacent companies, in some cases co-investing with sector-specialist or institutional partners. The website (agetechcapital.com) is live but currently displays a verification/loading state, and no headcount, office locations, founding-partner names, or LP roster are disclosed in the available sources.

The firm positions itself as a specialist in a structurally growing demographic segment — the over-65 population — targeting investment gaps where generalist capital is reportedly under-allocated. Operating geographies are not formally disclosed, but both known portfolio companies and several co-investors are Canada-based, suggesting an initial Canadian focus that may broaden as the fund matures.

Agetech Capital firmographics

Firmographics
Name
Agetech Capital
Website
https://agetechcapital.com
Company type
Private
Founded year
2022
Operating status
Operating
Short description
AgeTech Capital is a venture capital firm founded in 2022 that invests in early-stage technology companies serving the aging population and longevity economy, currently raising a $50M debut fund with portfolio investments in Canadian healthcare and fintech.
Ownership category
akta.pro rank

Agetech Capital industry classification

Industry
Product category
Venture Capital / Private Equity Investing
NAICS
Other Financial Investment Activities (5239), Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Financial Services / Fintech Growth Equity (FSANACAE)
akta.pro secondary industry
Technology & Software Growth Equity (FSANACAA)

Keywords

  • Venture capital fund
  • Agetech investments
  • Longevity economy
  • Aging population solutions
  • Healthcare technology investing

Agetech Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Agetech Capital product offering

Product offering

Core offering

AgeTech Capital is a venture capital fund that invests private capital into technology companies serving the aging population and the longevity economy. The firm provides equity financing and strategic support to early-stage and later-stage AgeTech startups developing aging-in-place solutions, healthcare technology, and financial services for older adults. The firm is currently raising a $50 million first fund dedicated to the AgeTech/longevity vertical.

Product overview

AgeTech Capital is a venture capital fund, not a product company. Based on the available source data, AgeTech Capital is described as raising a $50M first fund focused on AgeTech and longevity investing, with portfolio companies including June Health and Common Wealth.

Differentiator

Problem solved

Functional benefit

Products and services

  • AgeTech Capital Fund I A venture capital fund that invests in technology companies serving the aging population and the longevity economy. The fund deploys capital into early-stage and later-stage startups developing aging-in-place solutions, healthcare technology, and financial services for older adults. The product is targeted at limited partners (institutional investors, family offices, high-net-worth individuals) who commit capital to the fund.

Companies that use Agetech Capital

Customer profile

Segments1 record

Ideal customer profiles2 records

Agetech Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Agetech Capital partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Agetech Capital competitors and assessment

Company assessment

Direct peers

  • Generator Ventures: Venture firm focused exclusively on AgeTech and the longevity economy, investing across aging-in-place, healthcare, and senior care tech. Directly comparable by vertical, stage, and check size.
  • Longevity Vision Fund: Venture fund investing in technologies extending healthy human longevity, including healthspan, biotech, and AgeTech adjacencies. Comparable thematic focus with a broader biotech/healthspan overlay.
  • Primetime Partners: US-based venture firm investing in companies serving adults aged 50+. Closest direct peer given comparable AgeTech/longevity thesis and stage focus on consumer, healthcare, and financial services for older adults.
  • Ziegler Link-age Funds: Long-standing AgeTech-focused investment platform backed by Ziegler, targeting later-stage and growth equity opportunities in aging-services companies. Comparable vertical with a more growth-stage tilt.

Emerging players

  • The K Fund: Early-stage AgeTech-focused venture fund. Comparable by vertical and stage, though typically writing smaller initial checks than AgeTech Capital's profile.
  • Reckon Point Ventures: Emerging manager deploying capital into aging-services and senior-care technology businesses. Comparable by vertical though at earlier stage and smaller fund size.

Broad incumbents

  • Pivotal Ventures: Investment and incubation vehicle founded by Melinda French Gates, with explicit focus on aging/longevity among other priorities. Comparable thematic exposure but with much larger capital base and broader mandate.

Others

  • AgeTech West / AGE-WELL: Canadian aging-technology research and commercialization network. Comparable by geography and AgeTech focus, though structured as a research network rather than a pure VC fund — useful for sourcing and partnership comparisons.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Agetech Capital social profiles

Digital presence

Agetech Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Agetech Capital leadership team

Management profile

Number of profiles

Agetech Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Agetech Capital M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agetech Capital

What does Agetech Capital do?

AgeTech Capital is a venture capital fund that invests private capital into technology companies serving the aging population and the longevity economy. The firm provides equity financing and strategic support to early-stage and later-stage AgeTech startups developing aging-in-place solutions, healthcare technology, and financial services for older adults. The firm is currently raising a $50 million first fund dedicated to the AgeTech/longevity vertical.

Is Agetech Capital a public or private company?

Agetech Capital is a private company. It is classified as unknown and is currently operating.

When was Agetech Capital founded?

Agetech Capital was founded in 2022.

Who are Agetech Capital's main competitors?

Direct peers on record are Generator Ventures, Longevity Vision Fund, Primetime Partners and Ziegler Link-age Funds. Emerging players are The K Fund and Reckon Point Ventures. Pivotal Ventures is listed as a broad incumbent. AgeTech West / AGE-WELL is listed as an others.

Does Agetech Capital have an API?

No public API is recorded for Agetech Capital.

What industry is Agetech Capital in?

Agetech Capital's product category is Venture Capital / Private Equity Investing. Its primary akta.pro industry code is FSANACAE, Financial Services / Fintech Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 5239 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CoveragerSecurian Canada backs JuneJune Health, a Canadian women's healthcare platform, raised CAD$2.4 million with Securian Canada as a strategic institutional backer. The insurer joined AgeTech Capital and founders of PointClickCare and Financeit. Funds will build AI and data infrastructure, expand partnerships, and grow its care platform.MorningstarJune Health Announces $2.4 Million Funding Round With Strategic Investment From Securian CanadaJune Health announced an oversubscribed CAD$2.4 million financing round, with Securian Canada as a strategic institutional investor. The funding will accelerate its AI and data infrastructure, employer partnerships, and integrated care platform. The company aims to modernize women's healthcare access through clinician-trained AI.TechStartupsCritical Loop raises $26M to cut power connection delays from years to days with modular microgridsCritical Loop raised $26 million in a Series A led by Conifer Infrastructure Partners and Hanover, bringing total funding to $49 million. The startup's modular microgrids aim to cut power connection delays from years to days. It plans to expand beyond California, where grid congestion is acute.TechStartupsMicrosoft plans new Copilot features inspired by OpenClawMicrosoft is developing new Copilot features inspired by the open-source OpenClaw agent, with a team led by Omar Shahine exploring always-on agents. The initiative may be showcased at Build 2026, aiming to make Copilot a proactive assistant that works 24/7. Security concerns remain, but Microsoft is leveraging its infrastructure to make the approach viable at scale.NewswireCommon Wealth Raises $12 Million Series A to Expand Retirement Security for CanadiansCommon Wealth raised $12 million in equity financing to expand retirement security for Canadians. The round includes participation from investors like Broadbent and Flow Capital, and follows growth of its employer base by 3x since 2024. The funds will support platform expansion, AI investment, and member services.Thegerontechnologist2025 Guide to AgeTech Funds and Startup AcceleratorsThis article serves as a directory listing early-stage and later-stage venture capital funds focused on AgeTech investing, covering firms such as Equitage Ventures ($47M fund), Longevity Venture Partners ($30M fund), Cake Ventures ($17M first fund), Magnify Ventures ($52M fund), and Right at Home Corporate Ventures ($5M seed fund). The guide also profiles AgeTech Capital (raising $50M first fund) and Ziegler Link-age Funds (over $110M in committed capital), providing details on their investment focus areas, leadership, and notable portfolio companies. Each fund targets different segments of the aging and longevity market, including aging-in-place solutions, healthcare technology, and financial services for older adults.